NRX PHARMACEUTICALS INC's ticker is and the CUSIP is 629444950. A total of 3 filers reported holding NRX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,965 | -25.7% | 8,200 | +1.2% | 0.00% | – |
| Q1 2023 | $5,339 | -43.4% | 8,100 | -4.7% | 0.00% | – |
| Q4 2022 | $9,435 | +57.2% | 8,500 | -1.2% | 0.00% | – |
| Q3 2022 | $6,000 | -60.0% | 8,600 | -66.4% | 0.00% | – |
| Q2 2022 | $15,000 | -89.9% | 25,600 | -58.0% | 0.00% | – |
| Q1 2022 | $149,000 | -41.6% | 61,000 | +14.4% | 0.00% | – |
| Q4 2021 | $255,000 | +121.7% | 53,300 | +329.8% | 0.00% | – |
| Q3 2021 | $115,000 | – | 12,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 25,600 | $15,000 | 0.00% |
| SIMPLEX TRADING, LLC | 700 | $0 | 0.00% |